DOSE OF REALITY: REPORT FINDS BIG PHARMA RIDER IN TAX LAW LIKELY TO COST SENIORS AND TAXPAYERS FAR MORE THAN PREVIOUSLY ESTIMATED
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More

The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
Analysis Underscores How Anti-Competitive Tactics Like Patent Thicketing Keep… Read More
Big Pharma is at it again, working overtime to pass a policy that would cost… Read More
Reuters Analysis Finds Prices for Drugs First Entering the Market More Than… Read More
Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind… Read More
Brand Name Drug Companies Increase Prices By More Than Rate of Inflation in… Read More
Lawmakers Should Pass Bipartisan, Market-Based Solutions to Crack Down on… Read More
CBO Confirms Cost of Blockbuster Obesity Drugs at Current Prices Would… Read More
STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further… Read More
Brand Name Drug Companies Applying Price-Hiking, Patent Abuse Playbook to… Read More
Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing… Read More
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More